Dicot Pharma AB (FRA:KN0) Valuation Rank


FRA:KN0 Dicot Pharma AB FRA:KN0
28 GF Score
Price €0.01
! 2 Warning Signs
View Full Analysis

What is Dicot Pharma AB Valuation Rank?

The Valuation Rank measures the current valuation of a business relative to other companies in the same industry and its own historical valuation. The companies are split in equal numbers and then ranked from 1 to 10, with 10 as the most undervalued and 1 as the most overvalued.

  1. Three factors:
    • Absolute valuation (medpsvalue) relative to current stock price, rank among all companies
    • Historical valuation over the past 10 years. Rank pe, ps, pocf, ev2ebit over their own historical values
    • Industry relative valuation
  2. Companies without enough data is not ranked
  3. Companies with negative earnings are ranked lower

These three factors are used to calculate the value score for every eligible company, with values from 1 to 10. The final ranked companies are split in equal numbers and ranked from 1 to 10, with 10 as the most undervalued, and 1 as the most overvalued. The numbers of companies in each rank are the same.

Dicot Pharma AB Valuation Rank Related Terms

FRA:KN0
28GF Score
Dicot Pharma AB FRA:KN0
Valuation Rank is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Dicot Pharma AB Business Description

Other Exchanges DICOT:SwedenKN0:Germany
Address S:t Olofsgatan 11A, Uppsala, SWE, SE 753 21
Dicot Pharma AB is developing a modern potency medicine that will treat erectile dysfunction and premature ejaculation than existing preparations. The business model involves evaluating industrial and financial partnerships during clinical development to bring LIB-01 to commercialization on the world market. The company's drug candidate LIB-01 has a longer duration of action and fewer side effects, and is also used in the treatment of erectile dysfunction and premature ejaculation.
28GF Score

Get the complete analysis for FRA:KN0

Valuation Rank is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.01
Price